THURSDAY, May 7, 2020 (HealthDay News) — In the scramble to find medicines that beat back COVID-19, researchers from Italy report encouraging results from a small study on a rheumatoid arthritis drug already in use. The drug, anakinra, may help quiet the runaway immune response known as a “cytokine storm,” which imperils some patients with severe COVID-19. “Until a vaccine is available, we urgently need to find a way to help people survive the most severe symptoms of COVID-19, and to do that without overwhelming the intensive care capacity of hospitals,” explained study author Dr. Lorenzo Dagna in a news release from The Lancet Rheumatology. His team published the findings in the journal on May 7.

 

 

Credit: iStock, Fahroni

Read more…